Skin Cancer - Basal and Squamous Cell

FDA Approves Odomzo (Sonidegib) for Basal Cell Skin Cancer

How to Spot Skin Cancer

Skin cancer is by far the most common type of cancer. If you know what to look for, you can spot warning signs of skin cancer early.

Surgeon General Calls for Action to Prevent Skin Cancer

The US Surgeon General’s office is drawing national attention to skin cancer, calling it a major public health problem that requires immediate action.

Deadly Myths About Skin Cancer

Many people are unaware of skin cancer's dangers, and they may be underestimating their risks. Here we bust some common myths about this very common form of cancer so that you can be in the know – and protect your health.

FDA Requires Warning on Tanning Beds

The US Food and Drug Administration (FDA) says people under age 18 should not use tanning booths/beds or sunlamps, and these products will now have to carry a warning stating that. These devices have been re-classified as moderate risk (Class II) instead of low risk (Class I).

FDA Approves Drug for Basal Cell Carcinoma

The US Food and Drug Administration (FDA) has approved the first drug specifically for basal cell carcinoma, the most common type of skin cancer. The drug is called vismodegib (Erivedge)